Pharmacological activation of nrf2 pathway improves pancreatic islet isolation and transplantation

Cell Transplantation

Volumn 24, Issue 11, 2015, Pages 2273-2283

  Li, Shiri ^a   Vaziri, Nosratola D ^a   Masuda, Yuichi ^a   Hajighasemi Ossareh, Mohammad ^a   Robles, Lourdes ^a   Le, Aimee ^a   Vo, Kelly ^a   Chan, Jefferson Y ^a   Foster, Clarence E ^a   Stamos, Michael J ^a   Ichii, Hirohito ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Islet; Isolation; Nuclear erythroid 2 related factor 2 (Nrf2); Oxidative stress; Reactive oxygen species; Transplantation

Indexed keywords

AGENTS AFFECTING PROTEIN METABOLISM; BARDOXOLONE METHYL; DH 404; GLUCOSE; HEME OXYGENASE 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; DH404 COMPOUND; NFE2L2 PROTEIN, MOUSE; OLEANOLIC ACID; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ISOLATION; CELL PROTECTION; CELL SUSPENSION; CELL TRANSPLANTATION; CELL VIABILITY; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG POTENCY; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CAPSULE; MALE; MOUSE; NECROSIS; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; WESTERN BLOTTING; WILD TYPE; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMICALLY INDUCED; DEFICIENCY; DRUG EFFECTS; GENETICS; NUDE MOUSE; PANCREAS ISLET TRANSPLANTATION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CELL SURVIVAL; DIABETES MELLITUS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, NUDE; NF-E2-RELATED FACTOR 2; OLEANOLIC ACID; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STREPTOZOCIN;

EID: 84938369740     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368915X686210     Document Type: Article

References (58)

1. Acharya, J. D.; Ghaskadbi, S. S. Islets and their antioxidant defense. Islets 2(4):225–235; 2010.
2. Aminzadeh, M. A.; Reisman, S. A.; Vaziri, N. D.; Khazaeli, M.; Yuan, J.; Meyer, C. J. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease. Xenobiotica 44(6):570–578; 2014.
3. Azevedo-Martins, A. K.; Lortz, S.; Lenzen, S.; Curi, R.; Eizirik, D. L.; Tiedge, M. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Diabetes 52(1):93–101; 2003.
4. Barnett, M. J.; McGhee-Wilson, D.; Shapiro, A. M.; Lakey, J. R. Variation in human islet viability based on different membrane integrity stains. Cell Transplant. 13(5):481–488; 2004.
5. Chan, K.; Lu, R.; Chang, J. C.; Kan, Y. W. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc. Natl. Acad. Sci. USA 93(24):13943–13948; 1996.
6. Cho, H. Y.; Jedlicka, A. E.; Reddy, S. P.; Kensler, T. W.; Yamamoto, M.; Zhang, L. Y.; Kleeberger, S. R. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 26(2):175–182; 2002.
7. Cho, H. Y.; Reddy, S. P.; Debiase, A.; Yamamoto, M.; Kleeberger, S. R. Gene expression profiling of NRF2mediated protection against oxidative injury. Free Radic. Biol. Med. 38(3):325–343; 2005.
8. Copple, I. M.; Goldring, C. E.; Kitteringham, N. R.; Park, B. K. The Nrf2-Keap1 defence pathway: Role in protection against drug-induced toxicity. Toxicology 246(1):24–33; 2008.
9. Coskun, O.; Kanter, M.; Korkmaz, A.; Oter, S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol. Res. 51(2):117–123; 2005.
10. Deshane, J.; Wright, M.; Agarwal, A. Heme oxygenase-1 expression in disease states. Acta Biochim. Pol. 52(2):273–284; 2005.
11. Dinkova-Kostova, A. T.; Liby, K. T.; Stephenson, K. K.; Holtzclaw, W. D.; Gao, X.; Suh, N.; Williams, C.; Risingsong, R.; Honda, T.; Gribble, G. W.; Sporn, M.B.; Talalay, P. Extremely potent triterpenoid inducers of the phase 2 response: Correlations of protection against oxidant and inflammatory stress. Proc. Natl. Acad. Sci. USA 102(12):4584–4589; 2005.
12. Giudice, A.; Arra, C.; Turco, M. C. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents. Methods Mol. Biol. 647:37–74; 2010.
13. Giudice, A.; Montella, M. Activation of the Nrf2-ARE signaling pathway: A promising strategy in cancer prevention. Bioessays 28(2):169–181; 2006.
14. Gorogawa, S.; Kajimoto, Y.; Umayahara, Y.; Kaneto, H.; Watada, H.; Kuroda, A.; Kawamori, D.; Yasuda, T.; Matsuhisa, M.; Yamasaki, Y.; Hori, M. Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 57(1):1–10; 2002.
15. Gotoh, M.; Maki, T.; Kiyoizumi, T.; Satomi, S.; Monaco, A. P. An improved method for isolation of mouse pancreatic islets. Transplantation 40(4):437–438; 1985.
16. Grankvist, K.; Marklund, S. L.; Taljedal, I. B. CuZnsuperoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 199(2):393–398; 1981.
17. Halliwell, B.; Gutteridge, J. M.; Cross, C. E. Free radicals, antioxidants, and human disease: Where are we now? J. Lab. Clin. Med. 119(6):598–620; 1992.
18. Hennige, A. M.; Lembert, N.; Wahl, M. A.; Ammon, H. P. Oxidative stress increases potassium efflux from pancreatic islets by depletion of intracellular calcium stores. Free Radic. Res. 33(5):507–516; 2000.
19. Hotta, M.; Tashiro, F.; Ikegami, H.; Niwa, H.; Ogihara, T.; Yodoi, J.; Miyazaki, J. Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J. Exp. Med. 188(8):1445–1451; 1998.
20. Ichii, H.; Inverardi, L.; Pileggi, A.; Molano, R. D.; Cabrera, O.; Caicedo, A.; Messinger, S.; Kuroda, Y.; Berggren, P. O.; Ricordi, C. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am. J. Transplant. 5(7):1635–1645; 2005.
21. Ichii, H.; Miki, A.; Yamamoto, T.; Molano, R. D.; Barker, S.; Mita, A.; Rodriguez-Diaz, R.; Klein, D.; Pastori, R.; Alejandro, R.; Inverardi, L.; Pileggi, A.; Ricordi, C. Characterization of pancreatic ductal cells in human islet preparations. Lab. Invest. 88(11):1167–1177; 2008.
22. Ichii, H.; Ricordi, C. Current status of islet cell transplantation. J. Hepatobiliary Pancreat. Surg. 16(2):101–112; 2009.
23. Kapturczak, M. H.; Wasserfall, C.; Brusko, T.; Campbell Thompson, M.; Ellis, T. M.; Atkinson, M. A.; Agarwal, A. Heme oxygenase-1 modulates early inflammatory responses: Evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 165(3):1045–1053; 2004.
24. Katori, M.; Busuttil, R. W.; Kupiec-Weglinski, J. W. Heme oxygenase-1 system in organ transplantation. Transplantation 74(7):905–912; 2002.
25. Kaufman, D. B.; Gores, P. F.; Field, M. J.; Farney, A. C.; Gruber, S. A.; Stephanian, E.; Sutherland, D. E. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 43(6):778–783; 1994.
26. Kin, T. Islet isolation for clinical transplantation. Adv. Exp. Med. Biol. 654:683–710; 2010.
27. Kobayashi, M.; Yamamoto, M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Redox. Signal 7(3–4):385–394; 2005.
28. Kundu, J. K.; Surh, Y. J. Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis. Pharm. Res. 27(6):999–1013; 2010.
29. Lei, X. G.; Vatamaniuk, M. Z. Two tales of antioxidant enzymes on beta cells and diabetes. Antioxid. Redox. Signal 14(3):489–503; 2011.
30. Lenzen, S.; Drinkgern, J.; Tiedge, M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20(3): 463–466; 1996.
31. Li, W.; Kong, A. N. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 48(2):91–104; 2009.
32. Li, W.; Wu, W.; Song, H.; Wang, F.; Li, H.; Chen, L.; Lai, Y.; Janicki, J. S.; Ward, K. W.; Meyer, C. J.; Wang, X.; Tang, D.; Cui, T. Targeting Nrf2 by dihydro-CDDO-trifluoroethyl amide enhances autophagic clearance and viability of beta-cells in a setting of oxidative stress. FEBS Lett. 588(12):2115–2124; 2014.
33. Liby, K. T.; Yore, M. M.; Sporn, M. B. Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer. Nat. Rev. Cancer 7(5):357–369; 2007.
34. Like, A. A.; Rossini, A. A. Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus. Science 193(4251):415–417; 1976.
35. Meghana, K.; Sanjeev, G.; Ramesh, B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: A prophylactic and protective role. Eur. J. Pharmacol. 577(1–3):183–191; 2007.
36. Miwa, I.; Ichimura, N.; Sugiura, M.; Hamada, Y.; Taniguchi, S. Inhibition of glucose-induced insulin secretion by 4hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology 141(8):2767–2772; 2000.
37. Modak, M. A.; Datar, S. P.; Bhonde, R. R.; Ghaskadbi, S. S. Differential susceptibility of chick and mouse islets to streptozotocin and its co-relation with islet antioxidant status. J. Comp. Physiol. B.177(2):247–257; 2007.
38. Pi, J.; Zhang, Q.; Fu, J.; Woods, C. G.; Hou, Y.; Corkey, B. E.; Collins, S.; Andersen, M. E. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol. Appl. Pharmacol. 244(1):77–83; 2010.
39. Pileggi, A.; Molano, R. D.; Berney, T.; Cattan, P.; Vizzardelli, C.; Oliver, R.; Fraker, C.; Ricordi, C.; Pastori, R. L.; Bach, F. H.; Inverardi, L. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50(9):1983–1991; 2001.
40. Rabinovitch, A.; Suarez-Pinzon, W. L.; Strynadka, K.; Lakey, J. R.; Rajotte, R. V. Human pancreatic islet betacell destruction by cytokines involves oxygen free radicals and aldehyde production. J. Clin. Endocrinol. Metab. 81(9):3197–3202; 1996.
41. Ribeiro, M. M.; Klein, D.; Pileggi, A.; Molano, R. D.; Fraker, C.; Ricordi, C.; Inverardi, L.; Pastori, R. L. Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic beta-cells. Biochem. Biophys. Res. Commun. 305(4):876–881; 2003.
42. Robertson, R.; Zhou, H.; Zhang, T.; Harmon, J. S. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem. Biophys. 48(2– 3):139–146; 2007.
43. Robertson, R. P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279(41):42351–42354; 2004.
44. Robertson, R. P. Islet transplantation as a treatment for diabetes - A work in progress. N. Engl. J. Med. 350(7): 694–705; 2004.
45. Robertson, R. P. Oxidative stress and impaired insulin secretion in type 2 diabetes. Curr. Opin. Pharmacol. 6(6):615–619; 2006.
46. Ryan, E. A.; Lakey, J. R.; Paty, B. W.; Imes, S.; Korbutt, G. S.; Kneteman, N. M.; Bigam, D.; Rajotte, R. V.; Shapiro, A. M. Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes 51(7):2148–2157; 2002.
47. Sawada, T.; Matsumoto, I.; Nakano, M.; Kirchhof, N.; Sutherland, D. E.; Hering, B. J. Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation 75(12): 1965–1969; 2003.
48. Shapiro, A. M.; Lakey, J. R.; Ryan, E. A.; Korbutt, G. S.; Toth, E.; Warnock, G. L.; Kneteman, N. M.; Rajotte, R. V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 343(4):230–238; 2000.
49. Sporn, M. B.; Liby, K. T.; Yore, M. M.; Fu, L.; Lopchuk, J. M.; Gribble, G. W. New synthetic triterpenoids: Potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J. Nat. Prod. 74(3):537–545; 2011.
50. Stocker, R.; Perrella, M. A. Heme oxygenase-1: A novel drug target for atherosclerotic diseases? Circulation 114(20): 2178–2189; 2006.
51. Surh, Y. J.; Kundu, J. K.; Na, H. K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 74(13):1526–1539; 2008.
52. Tiedge, M.; Lortz, S.; Drinkgern, J.; Lenzen, S. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46(11):1733–1742; 1997.
53. Tobiasch, E.; Gunther, L.; Bach, F. H. Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J. Investig. Med. 49(6):566–571; 2001.
54. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047–1053; 2004.
55. Wolff, S. P. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br. Med. Bull. 49(3):642–652; 1993.
56. Yagishita, Y.; Fukutomi, T.; Sugawara, A.; Kawamura, H.; Takahashi, T.; Pi, J.; Uruno, A.; Yamamoto, M. Nrf2 protects pancreatic beta-cells from oxidative and nitrosative stress in diabetic model mice. Diabetes 63(2):605–618; 2014.
57. Yates, M. S.; Tauchi, M.; Katsuoka, F.; Flanders, K. C.; Liby, K. T.; Honda, T.; Gribble, G. W.; Johnson, D. A.; Johnson, J. A.; Burton, N. C.; Guilarte, T. R.; Yamamoto, M.; Sporn M. B.; Kensler, T. W. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol. Cancer Ther. 6(1):154–162; 2007.
58. Zoja, C.; Corna, D.; Nava, V.; Locatelli, M.; Abbate, M.; Gaspari, F.; Carrara, F.; Sangalli, F.; Remuzzi, G.; Benigni, A. Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects. Am. J. Physiol. Renal Physiol. 304(6):F808–819; 2013.